Sandra A Mitchell

Author PubWeight™ 27.76‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The cancer survivor's prescription for living. Am J Nurs 2007 3.37
2 Sclerotic-type chronic GVHD of the skin: clinical risk factors, laboratory markers, and burden of disease. Blood 2011 1.83
3 The 2009-2013 research agenda for oncology nursing. Oncol Nurs Forum 2009 1.57
4 The symptom experience in the first 100 days following allogeneic hematopoietic stem cell transplantation (HSCT). Support Care Cancer 2008 1.25
5 Cognitive interviewing of the US National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). Qual Life Res 2013 1.21
6 A literature synthesis of symptom prevalence and severity in persons receiving active cancer treatment. Support Care Cancer 2013 1.21
7 National Institutes of Health chronic graft-versus-host disease staging in severely affected patients: organ and global scoring correlate with established indicators of disease severity and prognosis. Biol Blood Marrow Transplant 2013 1.18
8 Stakeholder perspectives on implementing the National Cancer Institute's patient-reported outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). Transl Behav Med 2011 1.07
9 Electronic toxicity monitoring and patient-reported outcomes. Cancer J 2011 1.06
10 Salivary gland involvement in chronic graft-versus-host disease: prevalence, clinical significance, and recommendations for evaluation. Biol Blood Marrow Transplant 2010 1.05
11 Cancer-related fatigue and its impact on functioning. Cancer 2013 1.05
12 Implementing evidence-based practice: effectiveness of a structured multifaceted mentorship programme. J Adv Nurs 2010 1.05
13 Modifying cancer-related fatigue by optimizing sleep quality. J Natl Compr Canc Netw 2008 1.00
14 Function, adjustment, quality of life and symptoms (FAQS) in allogeneic hematopoietic stem cell transplantation (HSCT) survivors: a study protocol. Health Qual Life Outcomes 2011 0.98
15 Favorable outcomes in patients surviving 5 or more years after allogeneic hematopoietic stem cell transplantation for hematologic malignancies. Biol Blood Marrow Transplant 2010 0.95
16 Monitoring population health for Healthy People 2020: evaluation of the NIH PROMIS® Global Health, CDC Healthy Days, and satisfaction with life instruments. Qual Life Res 2012 0.95
17 Oral symptom intensity, health-related quality of life, and correlative salivary cytokines in adult survivors of hematopoietic stem cell transplantation with oral chronic graft-versus-host disease. Biol Blood Marrow Transplant 2010 0.89
18 Health-related quality of life in older adult survivors of selected cancers: data from the SEER-MHOS linkage. Cancer 2014 0.87
19 Cognitive impairment in patients with brain tumors: assessment and intervention in the clinic setting. Clin J Oncol Nurs 2006 0.83
20 Sleep-wake functioning along the cancer continuum: focus group results from the Patient-Reported Outcomes Measurement Information System (PROMIS(®)). Psychooncology 2010 0.80
21 Deriving clinically meaningful cut-scores for fatigue in a cohort of breast cancer survivors: a Health, Eating, Activity, and Lifestyle (HEAL) Study. Qual Life Res 2013 0.80
22 Child and parent perspectives of the chronic graft-versus-host disease (cGVHD) symptom experience: a concept elicitation study. Support Care Cancer 2014 0.80
23 Spiritual well-being in long-term survivors with chronic graft-versus-host disease after hematopoietic stem cell transplantation. J Support Oncol 2010 0.79
24 The importance of symptom surveillance during follow-up care of leukemia, bladder, and colorectal cancer survivors. Support Care Cancer 2013 0.79
25 Evidence-based guidelines for the management of neutropenia following outpatient hematopoietic stem cell transplantation. Clin J Oncol Nurs 2004 0.77
26 Acute renal failure: early detection and prompt intervention can improve outcomes. Am J Nurs 2002 0.75
27 Erratum to "Salivary Gland Involvement in Chronic Graft-versus-Host Disease: Prevalence, Clinical Significance, and Recommendations for Evaluation" [Biol Blood Marrow Transplant 16:1362-1369]. Biol Blood Marrow Transplant 2015 0.75